Lazard (LAZ) Q3 2026 Earnings Call Transcript

Lazard reported third-quarter adjusted net revenue of $805 million, up 11% year over year, while adjusted diluted EPS fell to $0.36 from $0.56. Financial advisory revenue rose 10% to $465 million and asset management revenue increased 12% to $330 million; asset management had record nine-month gross inflows of $54 billion, though third-quarter net outflows were $2.3 billion. Management said its weighted 2027 pipeline was more than double the comparable 2026 pipeline a year earlier and expects the Campbell Lutyens acquisition to contribute about $500 million of revenue in 2027; higher rates and valuation gaps continue to delay a significant pickup in private-equity M&A.

Analysis

LAZ: underlying advisory momentum is improving, but the near-term earnings signal is less clean than the revenue and pipeline narrative. A potential reduction in deferred compensation would pull expense forward into 2026 without changing awards; it may therefore weigh on reported earnings now while reducing future amortization and share dilution. Treat any near-term comp-ratio deterioration as accounting noise only if management confirms the policy change and awarded compensation remains disciplined.

The key debate is conversion, not pipeline size. A probability-weighted pipeline is not contracted revenue, and stronger strategic M&A may coexist with a lagging sponsor exit cycle. That mix could support advisory activity while delaying private-equity deal fees; secondaries activity and Lazard CL may partly offset the gap, but the expected 2027 contribution and referral synergies still require execution and integration. In asset management, benchmark performance and gross sales are constructive, but quarterly net outflows show that performance has not yet translated reliably into retained assets and recurring fees.

Near term, the market may discount the lower adjusted EPS and flat compensation ratio more heavily than forward indicators. Over 1–3 months, watch the Campbell Lutyens closing, the compensation-policy decision, and evidence that annual net flows turn positive. Over 6–18 months, advisory mandate conversion and realized operating efficiencies matter more than management’s pipeline claims. The contrarian upside is that Lazard could be gaining share even if industry-wide deal activity moderates; the downside is that a strong pipeline masks delayed closes and sponsor-related weakness. No valuation or price data are supplied, so avoid an unconditional price target or aggressive entry.

Key Decisions for Investors

• Maintain a measured long bias in LAZ rather than chasing the earnings-call optimism. Consider adding only after price action stabilizes and the market has absorbed the compensation-accounting uncertainty; reassess if advisory revenue or guidance weakens despite the stated pipeline.
• Track the Campbell Lutyens closing in early November and subsequent disclosures against the expected 2027 revenue contribution. Treat referral synergies as upside, not base case, until evidenced by results; integration delays or a downward revision would undermine the thesis.
• Use quarterly net flows—not gross inflows or benchmark outperformance alone—as the asset-management confirmation signal. Persistent outflows would challenge the assumed recurring-fee improvement; sustained positive net flows would strengthen the long case.
• Monitor whether the 2027 weighted pipeline converts into announced and completed mandates, especially sponsor-led transactions. A widening gap between pipeline indicators and realized advisory revenue is the clearest thesis falsifier; renewed rate increases or a sharper valuation disconnect could prolong the delay.